Results from phase 3 trial show baricitinib reduces deaths from COVID-19
The latest results from a study to assess the efficacy of the arthritis drug, baricitinib, in treating COVID-19 patients have
Read more
The latest results from a study to assess the efficacy of the arthritis drug, baricitinib, in treating COVID-19 patients have
Read more8 December 2020 — Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222,
Read moreThe first vaccines are only weeks away but the winter is looking bleak for the United States, where the coronavirus
Read moreKENILWORTH, N.J.–(BUSINESS WIRE) November 16, 2020 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada,
Read morePRINCETON, N.J.–(BUSINESS WIRE) November 3, 2020 — Bristol Myers Squibb (NYSE:BMY) today announced positive results from POETYK PSO-1, the first
Read moreThe coronavirus pandemic has passed grim milestones as Brazil confirmed one million infections and Europe chalked up more than 2.5
Read moreUS biotech firm Moderna reported “positive interim” results on Monday in the first clinical tests of its vaccine against the
Read more